Jolanda Howe - Jan 6, 2024 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
SVP, GLOBAL CONTROLLER
Signature
/s/ Judit Ryvkin, Attorney-in-Fact
Stock symbol
MIRM
Transactions as of
Jan 6, 2024
Transactions value $
-$14,803
Form type
4
Date filed
1/9/2024, 08:09 PM
Previous filing
Dec 6, 2023
Next filing
Jan 25, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Options Exercise +1.25K 1.25K Jan 6, 2024 Direct F1
transaction MIRM Common Stock Sale -$14.8K -528 -42.24% $28.04 722 Jan 8, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MIRM Restricted Stock Units Options Exercise $0 -1.25K -50% $0.00 1.25K Jan 6, 2024 Common Stock 1.25K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer).
F2 Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.
F3 The restricted stock units vest in a series of three successive equal annual installments beginning January 6, 2023. 1,250 shares vested on each of January 6, 2023 and January 6, 2024 and the remaining 1,250 shares will vest on January 6, 2025.